TY - JOUR
T1 - IMRT versus 2D/3D conformal RT in oropharyngeal cancer
T2 - A review of the literature and meta-analysis
AU - Alterio, Daniela
AU - Gugliandolo, Simone Giovanni
AU - Augugliaro, Matteo
AU - Marvaso, Giulia
AU - Gandini, Sara
AU - Bellerba, Federica
AU - Russell-Edu, Samuel William
AU - De Simone, Irene
AU - Cinquini, Michela
AU - Starzyńska, Anna
AU - Zaffaroni, Mattia
AU - Bacigalupo, Almalina
AU - Fanetti, Giuseppe
AU - Durante, Stefano
AU - Dicuonzo, Samantha
AU - Orecchia, Roberto
AU - Jereczek-Fossa, Barbara Alicja
N1 - © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2021/10
Y1 - 2021/10
N2 - Based on literature, intensity-modulated radiation therapy (IMRT) provides less related toxicity compared with conventional 2D/3D-RT with no impact on oncological outcomes for oropharyngeal cancer. The aim of this systematic review and meta-analysis is to assess whether IMRT might provide similar clinical outcomes with reduced related toxicity in comparison with conventional 2D/3D RT in patients treated for clinically advanced oropharyngeal cancer (OPC). Inclusion criteria for paper selection included: squamous OPC patients, treatment performed by concomitant CRT or RT alone, four treatment performed for curative intent, and presence of clinical outcome of interest, namely, overall survival (OS) and disease-free survival (DFS) and full paper available in English. Acute and late toxicities were retrieved together with OS and DFS. Crude relative risk estimates of relapse and death comparing 2D/3D-RT versus IMRT were calculated from tabular data, extracting events at 2-3 years of follow-up. Eight studies were selected. Six of them were included in the meta-analysis considering summary relative risk. Considering both acute and late toxicities, the considered studies evidenced advantages for IMRT populations, with the 2D/3D-RT population showing higher frequencies than the IMRT one. No statistical difference between IMRT and 2D/3D-RT in terms of death (SRR = 0.93, 95% CI: 0.83-1.04 with no heterogeneity I2 = 0%) and relapse (SRR = 0.92, 95% CI: 0.83-1.03, with no heterogeneity I2 = 0%) was found. Results of our study suggest the improvement in the therapeutic index with IMRT with evidenced reduced toxicity without any worsening in clinical outcome when compared to 2D/3DCRT.
AB - Based on literature, intensity-modulated radiation therapy (IMRT) provides less related toxicity compared with conventional 2D/3D-RT with no impact on oncological outcomes for oropharyngeal cancer. The aim of this systematic review and meta-analysis is to assess whether IMRT might provide similar clinical outcomes with reduced related toxicity in comparison with conventional 2D/3D RT in patients treated for clinically advanced oropharyngeal cancer (OPC). Inclusion criteria for paper selection included: squamous OPC patients, treatment performed by concomitant CRT or RT alone, four treatment performed for curative intent, and presence of clinical outcome of interest, namely, overall survival (OS) and disease-free survival (DFS) and full paper available in English. Acute and late toxicities were retrieved together with OS and DFS. Crude relative risk estimates of relapse and death comparing 2D/3D-RT versus IMRT were calculated from tabular data, extracting events at 2-3 years of follow-up. Eight studies were selected. Six of them were included in the meta-analysis considering summary relative risk. Considering both acute and late toxicities, the considered studies evidenced advantages for IMRT populations, with the 2D/3D-RT population showing higher frequencies than the IMRT one. No statistical difference between IMRT and 2D/3D-RT in terms of death (SRR = 0.93, 95% CI: 0.83-1.04 with no heterogeneity I2 = 0%) and relapse (SRR = 0.92, 95% CI: 0.83-1.03, with no heterogeneity I2 = 0%) was found. Results of our study suggest the improvement in the therapeutic index with IMRT with evidenced reduced toxicity without any worsening in clinical outcome when compared to 2D/3DCRT.
KW - Humans
KW - Neoplasm Recurrence, Local/radiotherapy
KW - Oropharyngeal Neoplasms/radiotherapy
KW - Radiotherapy, Conformal/adverse effects
KW - Radiotherapy, Intensity-Modulated/adverse effects
KW - Treatment Outcome
U2 - 10.1111/odi.13599
DO - 10.1111/odi.13599
M3 - Review article
C2 - 32810381
SN - 1354-523X
VL - 27
SP - 1644
EP - 1653
JO - Oral Diseases
JF - Oral Diseases
IS - 7
ER -